BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 17639530)

  • 41. Naturally occurring asbestos: a recurring public policy challenge.
    Lee RJ; Strohmeier BR; Bunker KL; Van Orden DR
    J Hazard Mater; 2008 May; 153(1-2):1-21. PubMed ID: 18180100
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The public's belief about biology.
    Wolpert L
    Biochem Soc Trans; 2007 Feb; 35(Pt 1):37-40. PubMed ID: 17212585
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Seeds of discontent: expert opinion, mass media messages, and the public image of agricultural biotechnology.
    Priest SH; Gillespie AW
    Sci Eng Ethics; 2000 Oct; 6(4):529-39; discussion 541-2. PubMed ID: 11228775
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Health and nutrition claims made on food: what future?].
    Laplace JP
    Bull Acad Natl Med; 2006 Nov; 190(8):1663-80; discussion 1680-2. PubMed ID: 17650751
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Public knowledge, public trust: understanding the 'knowledge deficit'.
    Brunk CG
    Community Genet; 2006; 9(3):178-83. PubMed ID: 16741347
    [TBL] [Abstract][Full Text] [Related]  

  • 46. An Asian perspective on GMO and biotechnology issues.
    Teng PP
    Asia Pac J Clin Nutr; 2008; 17 Suppl 1():237-40. PubMed ID: 18296345
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The association of knowledge with concern about global warming: trusted information sources shape public thinking.
    Malka A; Krosnick JA; Langer G
    Risk Anal; 2009 May; 29(5):633-47. PubMed ID: 19302280
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Systems architecture: a new model for sustainability and the built environment using nanotechnology, biotechnology, information technology, and cognitive science with living technology.
    Armstrong R
    Artif Life; 2010; 16(1):73-87. PubMed ID: 19857144
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The animal scientist in a changing society.
    Spencer S
    Domest Anim Endocrinol; 1999 Oct; 17(2-3):95-100. PubMed ID: 10527113
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Biotechnology and sustainability: the role of transatlantic cooperation in research and innovation.
    Aguilar A; Bochereau L; Matthiessen-Guyader L
    Trends Biotechnol; 2008 Apr; 26(4):163-5. PubMed ID: 18295918
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Media(ted) fabrications: how the science-media symbiosis helped 'sell' cord banking.
    Michelle C
    Commun Med; 2006; 3(1):55-68. PubMed ID: 16808425
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Raising the social yield of research: challenge facing biotechnology.
    Grimaud JA
    Cell Mol Biol (Noisy-le-grand); 2001 Dec; 47(8):1257-60. PubMed ID: 11838945
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mastering the key elements of working with the media.
    Cloud D
    Issue Brief Cent Medicare Educ; 2005; 5(9):1-6. PubMed ID: 15696642
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Personal and public perceptions of radiation risks.
    Hendee WR
    Radiographics; 1991 Nov; 11(6):1109-19. PubMed ID: 1749852
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Integrated farming: why organic farmers should use transgenic crops.
    Ammann K
    N Biotechnol; 2008; 25(2-3):101-7. PubMed ID: 18824150
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Gene therapy and the public: a matter of trust.
    Gottweis H
    Gene Ther; 2002 Jun; 9(11):667-9. PubMed ID: 12032683
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Controlled randomized clinical trials].
    Jaillon P
    Bull Acad Natl Med; 2007; 191(4-5):739-56; discussion 756-8. PubMed ID: 18225427
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Competence-based and integrity-based trust as predictors of acceptance of carbon dioxide capture and storage (CCS).
    Terwel BW; Harinck F; Ellemers N; Daamen DD
    Risk Anal; 2009 Aug; 29(8):1129-40. PubMed ID: 19572967
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Procedures and methods of benefit assessments for medicines in Germany].
    Bekkering GE; Kleijnen J
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.